Lv7
5000 积分 2021-05-20 加入
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
2年前
已完结
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
2年前
已完结
Sense codon reassignment enables viral resistance and encoded polymer synthesis
2年前
已完结
